Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Jingjing
STOP-PA, NCT06523465: Statin Combined with Amlodipine Treats Primary Aldosteronism	Recruiting	4	180	RoW	Simvastatin combined with Amlodipine besylate, Simvastatin combined with Spironolactone and Amlodipine besylate., Amlodipine besylate combined Spironolactone	Third Military Medical University	Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension	12/25	09/26
NCT06354530: A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma	Recruiting	2/3	266	RoW	anlotinib, Thoracic radiotherapy, radiotherapy	Army Medical Center of PLA	Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma	12/25	12/26
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer	Recruiting	2	64	RoW	GT101 injection, Gemcitabine injection	Grit Biotechnology	Adult	01/27	01/27
RWS-MTB, NCT06781151: A Study to Explore Personalized Treatment for Patients with Recurrent Gynecological Malignancies Based on MTB	Recruiting	N/A	200	RoW		Sun Yat-sen University	Ovarian Cancer Recurrent, Endometrial Cancer Recurrent, Cervical Cancer Recurrent	12/26	06/27
NCT05454878: Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy	Not yet recruiting	N/A	100	RoW		Chinese PLA General Hospital	Atrial Fibrillation	07/23	12/23